News
Learn more about whether ADMA Biologics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Detailed price information for Centessa Pharmaceuticals Plc ADR (CNTA-Q) from The Globe and Mail including charting and trades.
The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency ...
Gene therapy biotech Kriya Therapeutics has secured $313 million in a new series fundraise. | Gene therapy biotech Kriya ...
Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F.
Stock markets worldwide are sliding today as concerns intensify about the impact of US tariffs on the global economy. The US is set to launch reciprocal tariffs on Wednesday, and President Trump said ...
The FDA said data for PTC's drug did not prove "substantial evidence of efficacy." Elsewhere, the FDA delayed its decision on ...
3h
Investor's Business Daily on MSNViking Therapeutics Crashes 41% On Mixed Results For Its Weight-Loss Pill
Viking Therapeutics stock crashed Tuesday — losing more than a third of its value — on mixed results for its weight-loss pill ...
Preliminary data are expected this year for a Phase 1/2 clinical trial testing the investigational therapy SRP-1003 in DM1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results